JPRN-UMIN000020814
Recruiting
未知
sefulness of FDG-PET/CT to predict the response after nivolumab in patients with previously treated advanced non-small cell lung cancer - FDG-PET/CT and prediction of nivolumab in lung cancer
Gunma0 sites30 target enrollmentFebruary 1, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Previously treated advanced non-small cell lung cancer
- Sponsor
- Gunma
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Pregnant woman 2\) Patients with obvious interstitial pneumonia or pulmonary fibrosis in the chest X\-ray. 3\) Patients with collagen vascular disease or autoimmune diseases 4\) Other cases attending physician it is determined unsuitable for registration of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
sefulness of FDG-PET/CT to predict the response after anti-PD-1 antibody in patients with previously treated advanced non-small cell lung cancer: a multi-institutional studyPreviously treated advanced non-small cell lung cancerJPRN-UMIN000031009Gunma University120
Unknown
Not Applicable
sefulness of FDG-PET/CT to predict the response after pembrolizumab in patients with PD-L1 positive advanced non-small cell lung canceradvanced non-small cell lung cancerJPRN-UMIN000026730Gunma University Hospital50
Completed
Not Applicable
sefulness of FDG-PET/CT examination as prediction of effect of immune checkpoint inhibitors in patients with non-small cell lung cancer : a pilot studyadvanced and recurrent non-small cell lung cancerJPRN-UMIN000031095Kansai Medical University30
Active, not recruiting
Not Applicable
se of the PET-Scan examination in the evaluation of the treatment of patients diagnosed with Head and Neck CancerScamous Cell- Carcinoma of Head and NeckNeoplasmsPositron Emission Tomography Computed TomographyC04.557.470.200.400E01.370.350.350.800.700.500RBR-9wwstdAC Camargo Cancer Center
Recruiting
Phase 1
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITOR-PILOT)Metastatic breast cancerTherapeutic area: Diseases [C] - Neoplasms [C04]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]CTIS2023-506550-20-00Odense University Hospital30